Pharma IP Circle

It's time to say goodbye to 2020 & also this blog. As most of the you are aware that "Pharma IP Circle" has moved to new a...

  On Dec. 21, 2020, Federal Circuit affirmed district court’s summary judgment that found infringement under Doctrine of Equivalents (DoE). ...

Dear Readers, Happy to share that "Pharma IP Circle" blog has moved from blogger to full fledged secure website. Please subscribe ...

  On Dec. 18, 2020, Federal Circuit affirmed (Rule 36 judgment) Delaware court in Uceris ® litigation. Previously, Plaintiffs Bausch Heal...

  On Dec. 16, 2020, Federal Circuit affirmed (Rule 36 judgment) PTAB finding method of use patent invalid as obvious.You can find the IPR ...

  IPR decision: Dec. 08, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...

  On Dec. 04, 2020, UK High Court found second medical use patent valid & infringed by Mylan. Neurim holds EP 1,441,702 patent, which ...

  On Nov. 30, 2020, Delaware court on remand found Quillivant XR® patents valid & infringed by ANDA filer in a Hatch-Waxman suit. Plai...

  On Nov. 30, 2020, Delaware court found composition patent covering combination invalid as obvious & not infringing. Background of ...

  On Nov. 19, 2020, Federal Circuit affirmed judgment of infringement & damages against Glaxo. Plaintiff (Vectura Ltd) filed suit in 2...